143 related articles for article (PubMed ID: 24225910)
21. [Long-term treatment with intravitreal ranibizumab for exudative age-related macular degeneration].
Lukács R; Resch M; Papp A; Szabó A; Borbándy Á; Menkens H; Kiss H; Németh J
Orv Hetil; 2013 Nov; 154(45):1790-7. PubMed ID: 24184931
[TBL] [Abstract][Full Text] [Related]
22. Long-Term Follow-up of Patients with Exudative Age-Related Macular Degeneration Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
Kung FF; Starr MR; Bui YT; Mejia CA; Bakri SJ
Ophthalmol Retina; 2020 Nov; 4(11):1047-1053. PubMed ID: 32439455
[TBL] [Abstract][Full Text] [Related]
23. Anti-VEGF therapy in symptomatic peripheral exudative hemorrhagic chorioretinopathy (PEHCR) involving the macula.
Seibel I; Hager A; Duncker T; Riechardt AI; Nürnberg D; Klein JP; Rehak M; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):653-9. PubMed ID: 26148802
[TBL] [Abstract][Full Text] [Related]
24. [Visual and anatomical outcomes of three intravitreal aflibercept injections in eyes with neovascular form of age-related macular degeneration].
Kałuiny JJ; Majer A; Jaworowska-Cieślińska I
Klin Oczna; 2015; 117(1):9-13. PubMed ID: 26349151
[TBL] [Abstract][Full Text] [Related]
25. Predictive factors of visual and anatomical outcome after intravitreal bevacizumab treatment of neovascular age-related macular degeneration: an optical coherence tomography study.
Singh RP; Fu EX; Smith SD; Williams DR; Kaiser PK
Br J Ophthalmol; 2009 Oct; 93(10):1353-8. PubMed ID: 19556212
[TBL] [Abstract][Full Text] [Related]
26. Five-year treatment outcomes following intravitreal ranibizumab injections for neovascular age-related macular degeneration in Japanese patients.
Wada I; Oshima Y; Shiose S; Kano K; Nakao S; Kaizu Y; Yoshida S; Ishibashi T; Sonoda KH
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1411-1418. PubMed ID: 31119425
[TBL] [Abstract][Full Text] [Related]
27. Development and testing of a patient-derived questionnaire for treatment of neovascular age-related macular degeneration: dimensions of importance in treatment of neovascular age-related macular degeneration.
Jelin E; Wisløff T; Moe MC; Heiberg T
Acta Ophthalmol; 2018 Dec; 96(8):804-811. PubMed ID: 30198182
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and characteristics of macular atrophy in eyes with neovascular age-related macular degeneration. A study from a long-term observational dataset: the Fight Retinal Blindness! project.
Daien V; Nguyen V; Essex RW; Guymer R; Arnold JJ; Munk M; Ceklic L; Gillies MC; Barthelmes D;
Br J Ophthalmol; 2020 Aug; 104(8):1064-1069. PubMed ID: 31843790
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
[TBL] [Abstract][Full Text] [Related]
30. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
Rosenfeld PJ; Moshfeghi AA; Puliafito CA
Ophthalmic Surg Lasers Imaging; 2005; 36(4):331-5. PubMed ID: 16156152
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of monthly and fortnightly anti-VEGF treatments for age-related macular degeneration.
Nunes RP; Hirai FE; Barroso LF; Badaró E; Novais E; Rodrigues EB; Maia M; Magalhães O; Farah ME
Arq Bras Oftalmol; 2019; 82(3):225-232. PubMed ID: 30810619
[TBL] [Abstract][Full Text] [Related]
32. Comparison of intravitreal aflibercept and ranibizumab injections on subfoveal and peripapillary choroidal thickness in eyes with neovascular age-related macular degeneration.
Yun C; Oh J; Ahn J; Hwang SY; Lee B; Kim SW; Huh K
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1693-702. PubMed ID: 26781585
[TBL] [Abstract][Full Text] [Related]
33. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections.
Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH
Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476
[TBL] [Abstract][Full Text] [Related]
34. MACULAR CHOROIDAL VOLUME CHANGES AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
Palkovits S; Seidel G; Pertl L; Malle EM; Hausberger S; Makk J; Singer C; Osterholt J; Herzog SA; Haas A; Weger M
Retina; 2017 Dec; 37(12):2262-2268. PubMed ID: 28129216
[TBL] [Abstract][Full Text] [Related]
35. MACULAR ATROPHY AND MACULAR MORPHOLOGY IN AFLIBERCEPT-TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Kuroda Y; Yamashiro K; Ooto S; Tamura H; Oishi A; Nakanishi H; Miyata M; Hata M; Takahashi A; Wakazono T; Yoshimura N; Tsujikawa A
Retina; 2018 Sep; 38(9):1743-1750. PubMed ID: 28691937
[TBL] [Abstract][Full Text] [Related]
36. Predictive models of long-term anatomic outcome in age-related macular degeneration treated with as-needed Ranibizumab.
Gonzalez-Buendia L; Delgado-Tirado S; Sanabria MR; Fernandez I; Coco RM
BMC Ophthalmol; 2017 Aug; 17(1):147. PubMed ID: 28821236
[TBL] [Abstract][Full Text] [Related]
37. PROGNOSTIC VALUE OF SUBRETINAL HYPERREFLECTIVE MATERIAL IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED WITH BEVACIZUMAB.
Pokroy R; Mimouni M; Barayev E; Segev F; Geffen N; Nemet AY; Segal O
Retina; 2018 Aug; 38(8):1485-1491. PubMed ID: 28654630
[TBL] [Abstract][Full Text] [Related]
38. Lessons Learned From Avastin and OCT-The Great, the Good, the Bad, and the Ugly: The LXXV Edward Jackson Memorial Lecture.
Rosenfeld PJ
Am J Ophthalmol; 2019 Aug; 204():26-45. PubMed ID: 30851267
[TBL] [Abstract][Full Text] [Related]
39. One-year outcomes of less frequent bevacizumab in age-related macular degeneration.
Sonmez K; Sonmez PA; Ozkan SS; Atmaca LS
Retina; 2011 Apr; 31(4):645-53. PubMed ID: 21358363
[TBL] [Abstract][Full Text] [Related]
40. Macular atrophy in patients with long-term anti-VEGF treatment for neovascular age-related macular degeneration.
Munk MR; Ceklic L; Ebneter A; Huf W; Wolf S; Zinkernagel MS
Acta Ophthalmol; 2016 Dec; 94(8):e757-e764. PubMed ID: 27417506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
